ArticleACS nano2025
A Thermogenetic Tool Employing Elastin-like Polypeptides for Controlling Programmed Cell Death.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rational Design and One-Step Immobilization of Chitosanase for Specific and Recyclable Chitobiose Production.Foods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thermogenetics uses temperature-sensitive proteins to regulate cellular functions via temperature changes. Compared to optogenetics, which utilizes visible light and is limited by light penetration, thermogenetics offers a practical alternative by enabling deeper and more accessible control of cellular processes via heat. Herein, we report the development of a thermogenetically controlled programmed cell death system that enables heat-activated human caspase 8 (CASP8) using temperature-responsive elastin-like polypeptides (ELPs). The core functionality of this system relies on the reversible phase transition behavior of ELPs, which transition from a soluble state to a coacervate state in response to thermal stimuli. By exploiting this temperature-dependent behavior, we fused ELP[V60] with the catalytic domain of CASP8 to construct the ELP[V60]-CASP8 fusion. Upon heating at temperatures above 35 °C, the ELP[V60] in the fusion protein underwent coacervation, increasing the local concentration of CASP8 to facilitate dimerization-induced activation and promote cell death in HEK293T cells. We observed a correlation between the heating temperature and the duration required to induce cytotoxicity at higher temperatures, requiring shorter heating times. Additionally, we developed a CASP8 indicator to monitor CASP8 activation and demonstrated its functionality in HEK293T cells. We further used optical heating with a 1470 nm laser combined with fluorescence lifetime-based thermometry to achieve localized activation of CASP8 in target single cells with precise and controlled temperature increments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.